6-year outcomes in children whose mothers took nifedipine vs. placebo during pregnancy
Part of Women’s health & pregnancy clinical trials.
This study follows up on children whose mothers were part of the TOCOPREM trial, which tested nifedipine (a medication to prevent preterm birth) versus a placebo. Researchers want to see how these children are doing at age 6, focusing on their health and development.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child was born to a mother who participated in the TOCOPREM trial and agreed to the 2-year follow-up
- Your child is at least 6 years old and alive
- You have internet access and a good video-conference system for the psychological evaluation
- You agree to let your child take part in this follow-up study
- Your child does not have major birth defects or genetic problems found after birth
- We are able to contact your family
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is a long-term check-up for children who were in the TREOCAPA trial. It follows their health and development for about 2 years after they were in the original study.
This study checks on the health and development of children whose mothers took part in the PETN studies. It involves questionnaires and a physical exam for kids aged 5 and older.
This trial is testing a medication called nifedipine (a long-acting blood pressure pill) to see if it can help lower the risk of long-term high blood pressure and improve blood vessel health after a pregnancy complication like preeclampsia. It is for women who have just given birth and are still in the hospital.
This study follows mothers who previously joined two specific pregnancy research programs, to understand why some children may be more likely to develop weight and heart-related health problems later. If you were part of those original studies, your information could help researchers look for early predictors and prevention ideas.
This study looks at children’s neurodevelopment (how the brain, learning, and development are going) whose mothers took part in the earlier CONCEPTT trial. It may help researchers understand how having type 1 diabetes in pregnancy can relate to a child’s development.
This study follows up on children and mothers who were part of an earlier trial comparing inducing labor at 39 weeks versus waiting for labor to start naturally. The goal is to see how both groups are doing five years later.
Hear when a new Children Born to Mothers Enrolled in the TOCOPROM Trial trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.